List of Tables
Table 1. Global Prescription Diet Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Prescription Diet Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Prescription Diet Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Prescription Diet Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Prescription Diet Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Prescription Diet Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Prescription Diet Sales by Region (2020-2025) & (Tons)
Table 8. Global Prescription Diet Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Prescription Diet Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 11. Global Prescription Diet Production by Region (2020-2025) & (Tons)
Table 12. Global Prescription Diet Production by Region (2026-2031) & (Tons)
Table 13. Global Prescription Diet Sales by Manufacturers (2020-2025) & (Tons)
Table 14. Global Prescription Diet Sales Share by Manufacturers (2020-2025)
Table 15. Global Prescription Diet Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Prescription Diet Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Prescription Diet by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Diet as of 2024)
Table 19. Global Prescription Diet Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Prescription Diet Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
Table 21. Key Manufacturers Prescription Diet Manufacturing Base and Headquarters
Table 22. Global Prescription Diet Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Prescription Diet Sales by Type (2020-2025) & (Tons)
Table 26. Global Prescription Diet Sales by Type (2026-2031) & (Tons)
Table 27. Global Prescription Diet Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Prescription Diet Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Prescription Diet ASP by Type (2020-2031) & (US$/Ton)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Prescription Diet Sales by Application (2020-2025) & (Tons)
Table 32. Global Prescription Diet Sales by Application (2026-2031) & (Tons)
Table 33. Prescription Diet High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Prescription Diet Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Prescription Diet Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Prescription Diet ASP by Application (2020-2031) & (US$/Ton)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Prescription Diet Growth Accelerators and Market Barriers
Table 40. North America Prescription Diet Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Prescription Diet Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Prescription Diet Growth Accelerators and Market Barriers
Table 43. Europe Prescription Diet Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Prescription Diet Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Prescription Diet Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Prescription Diet Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Prescription Diet Growth Accelerators and Market Barriers
Table 48. Southeast Asia Prescription Diet Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Prescription Diet Investment Opportunities and Key Challenges
Table 50. Central and South America Prescription Diet Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Prescription Diet Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Prescription Diet Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Colgate-Palmolive Corporation Information
Table 54. Colgate-Palmolive Description and Major Businesses
Table 55. Colgate-Palmolive Product Models, Descriptions and Specifications
Table 56. Colgate-Palmolive Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 57. Colgate-Palmolive Sales Value Proportion by Product in 2024
Table 58. Colgate-Palmolive Sales Value Proportion by Application in 2024
Table 59. Colgate-Palmolive Sales Value Proportion by Geographic Area in 2024
Table 60. Colgate-Palmolive Prescription Diet SWOT Analysis
Table 61. Colgate-Palmolive Recent Developments
Table 62. Royal Canin Corporation Information
Table 63. Royal Canin Description and Major Businesses
Table 64. Royal Canin Product Models, Descriptions and Specifications
Table 65. Royal Canin Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 66. Royal Canin Sales Value Proportion by Product in 2024
Table 67. Royal Canin Sales Value Proportion by Application in 2024
Table 68. Royal Canin Sales Value Proportion by Geographic Area in 2024
Table 69. Royal Canin Prescription Diet SWOT Analysis
Table 70. Royal Canin Recent Developments
Table 71. Purina Corporation Information
Table 72. Purina Description and Major Businesses
Table 73. Purina Product Models, Descriptions and Specifications
Table 74. Purina Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Purina Sales Value Proportion by Product in 2024
Table 76. Purina Sales Value Proportion by Application in 2024
Table 77. Purina Sales Value Proportion by Geographic Area in 2024
Table 78. Purina Prescription Diet SWOT Analysis
Table 79. Purina Recent Developments
Table 80. Blue Buffalo Corporation Information
Table 81. Blue Buffalo Description and Major Businesses
Table 82. Blue Buffalo Product Models, Descriptions and Specifications
Table 83. Blue Buffalo Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 84. Blue Buffalo Sales Value Proportion by Product in 2024
Table 85. Blue Buffalo Sales Value Proportion by Application in 2024
Table 86. Blue Buffalo Sales Value Proportion by Geographic Area in 2024
Table 87. Blue Buffalo Prescription Diet SWOT Analysis
Table 88. Blue Buffalo Recent Developments
Table 89. Rayne Corporation Information
Table 90. Rayne Description and Major Businesses
Table 91. Rayne Product Models, Descriptions and Specifications
Table 92. Rayne Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Rayne Sales Value Proportion by Product in 2024
Table 94. Rayne Sales Value Proportion by Application in 2024
Table 95. Rayne Sales Value Proportion by Geographic Area in 2024
Table 96. Rayne Prescription Diet SWOT Analysis
Table 97. Rayne Recent Developments
Table 98. Natural Balance Corporation Information
Table 99. Natural Balance Description and Major Businesses
Table 100. Natural Balance Product Models, Descriptions and Specifications
Table 101. Natural Balance Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 102. Natural Balance Recent Developments
Table 103. IAMS Corporation Information
Table 104. IAMS Description and Major Businesses
Table 105. IAMS Product Models, Descriptions and Specifications
Table 106. IAMS Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 107. IAMS Recent Developments
Table 108. Key Raw Materials Distribution
Table 109. Raw Materials Key Suppliers
Table 110. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 111. Milestones in Production Technology Evolution
Table 112. Distributors List
Table 113. Market Trends and Market Evolution
Table 114. Market Drivers and Opportunities
Table 115. Market Challenges, Risks, and Restraints
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Prescription Diet Product Picture
Figure 2. Global Prescription Diet Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Wet Prescription Diet Product Picture
Figure 4. Dry Prescription Diet Product Picture
Figure 5. Global Prescription Diet Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Cat
Figure 7. Dog
Figure 8. Others
Figure 9. Prescription Diet Report Years Considered
Figure 10. Global Prescription Diet Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Prescription Diet Revenue (2020-2031) & (US$ Million)
Figure 12. Global Prescription Diet Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Prescription Diet Revenue Market Share by Region (2020-2031)
Figure 14. Global Prescription Diet Sales (2020-2031) & (Tons)
Figure 15. Global Prescription Diet Sales (CAGR) by Region (2020-2031) (Tons)
Figure 16. Global Prescription Diet Sales Market Share by Region (2020-2031)
Figure 17. Global Prescription Diet Capacity, Production and Utilization (2020-2031) & (Tons)
Figure 18. Global Prescription Diet Production Trend by Region (2020-2031) (Tons)
Figure 19. Global Prescription Diet Production Market Share by Region (2020-2031)
Figure 20. Production Capacity Enablers & Constraints
Figure 21. Prescription Diet Production Growth Rate in North America (2020-2031) & (Tons)
Figure 22. Prescription Diet Production Growth Rate in Europe (2020-2031) & (Tons)
Figure 23. Prescription Diet Production Growth Rate in China (2020-2031) & (Tons)
Figure 24. Prescription Diet Production Growth Rate in Japan (2020-2031) & (Tons)
Figure 25. Top 5 and Top 10 Manufacturers Prescription Diet Sales Volume Market Share in 2024
Figure 26. Global Prescription Diet Revenue Market Share Ranking (2024)
Figure 27. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 28. Wet Prescription Diet Revenue Market Share by Manufacturer in 2024
Figure 29. Dry Prescription Diet Revenue Market Share by Manufacturer in 2024
Figure 30. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 31. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 32. Global Prescription Diet Sales Market Share by Type (2020-2031)
Figure 33. Global Prescription Diet Revenue Market Share by Type (2020-2031)
Figure 34. Global Prescription Diet Sales Market Share by Application (2020-2031)
Figure 35. Global Prescription Diet Revenue Market Share by Application (2020-2031)
Figure 36. North America Prescription Diet Sales YoY (2020-2031) & (Tons)
Figure 37. North America Prescription Diet Revenue YoY (2020-2031) & (US$ Million)
Figure 38. North America Top 5 Manufacturers Prescription Diet Sales Revenue (US$ Million) in 2024
Figure 39. North America Prescription Diet Sales Volume (Tons) by Type (2020- 2031)
Figure 40. North America Prescription Diet Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 41. North America Prescription Diet Sales Volume (Tons) by Application (2020-2031)
Figure 42. North America Prescription Diet Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. US Prescription Diet Revenue (2020-2031) & (US$ Million)
Figure 44. Canada Prescription Diet Revenue (2020-2031) & (US$ Million)
Figure 45. Mexico Prescription Diet Revenue (2020-2031) & (US$ Million)
Figure 46. Europe Prescription Diet Sales YoY (2020-2031) & (Tons)
Figure 47. Europe Prescription Diet Revenue YoY (2020-2031) & (US$ Million)
Figure 48. Europe Top 5 Manufacturers Prescription Diet Sales Revenue (US$ Million) in 2024
Figure 49. Europe Prescription Diet Sales Volume (Tons) by Type (2020-2031)
Figure 50. Europe Prescription Diet Sales Revenue (US$ Million) by Type (2020-2031)
Figure 51. Europe Prescription Diet Sales Volume (Tons) by Application (2020-2031)
Figure 52. Europe Prescription Diet Sales Revenue (US$ Million) by Application (2020-2031)
Figure 53. Germany Prescription Diet Revenue (2020-2031) & (US$ Million)
Figure 54. France Prescription Diet Revenue (2020-2031) & (US$ Million)
Figure 55. U.K. Prescription Diet Revenue (2020-2031) & (US$ Million)
Figure 56. Italy Prescription Diet Revenue (2020-2031) & (US$ Million)
Figure 57. Russia Prescription Diet Revenue (2020-2031) & (US$ Million)
Figure 58. Asia-Pacific Prescription Diet Sales YoY (2020-2031) & (Tons)
Figure 59. Asia-Pacific Prescription Diet Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Asia-Pacific Top 8 Manufacturers Prescription Diet Sales Revenue (US$ Million) in 2024
Figure 61. Asia-Pacific Prescription Diet Sales Volume (Tons) by Type (2020- 2031)
Figure 62. Asia-Pacific Prescription Diet Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 63. Asia-Pacific Prescription Diet Sales Volume (Tons) by Application (2020-2031)
Figure 64. Asia-Pacific Prescription Diet Sales Revenue (US$ Million) by Application (2020-2031)
Figure 65. Indonesia Prescription Diet Revenue (2020-2031) & (US$ Million)
Figure 66. Japan Prescription Diet Revenue (2020-2031) & (US$ Million)
Figure 67. South Korea Prescription Diet Revenue (2020-2031) & (US$ Million)
Figure 68. China Taiwan Prescription Diet Revenue (2020-2031) & (US$ Million)
Figure 69. India Prescription Diet Revenue (2020-2031) & (US$ Million)
Figure 70. Central and South America Prescription Diet Sales YoY (2020-2031) & (Tons)
Figure 71. Central and South America Prescription Diet Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Central and South America Top 5 Manufacturers Prescription Diet Sales Revenue (US$ Million) in 2024
Figure 73. Central and South America Prescription Diet Sales Volume (Tons) by Type (2021-2031)
Figure 74. Central and South America Prescription Diet Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Central and South America Prescription Diet Sales Volume (Tons) by Application (2020-2031)
Figure 76. Central and South America Prescription Diet Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. Brazil Prescription Diet Revenue (2020-2025) & (US$ Million)
Figure 78. Argentina Prescription Diet Revenue (2020-2025) & (US$ Million)
Figure 79. Middle East, and Africa Prescription Diet Sales YoY (2020-2031) & (Tons)
Figure 80. Middle East and Africa Prescription Diet Revenue YoY (2020-2031) & (US$ Million)
Figure 81. Middle East and Africa Top 5 Manufacturers Prescription Diet Sales Revenue (US$ Million) in 2024
Figure 82. Middle East and Africa Prescription Diet Sales Volume (Tons) by Type (2021-2031)
Figure 83. South America Prescription Diet Sales Revenue (US$ Million) by Type (2020-2031)
Figure 84. Middle East and Africa Prescription Diet Sales Volume (Tons) by Application (2020-2031)
Figure 85. Middle East and Africa Prescription Diet Sales Revenue (US$ Million) by Application (2020-2031)
Figure 86. GCC Countries Prescription Diet Revenue (2020-2025) & (US$ Million)
Figure 87. Turkey Prescription Diet Revenue (2020-2025) & (US$ Million)
Figure 88. Egypt Prescription Diet Revenue (2020-2025) & (US$ Million)
Figure 89. South Africa Prescription Diet Revenue (2020-2025) & (US$ Million)
Figure 90. Prescription Diet Industry Chain Mapping
Figure 91. Regional Prescription Diet Manufacturing Base Distribution (%)
Figure 92. Prescription Diet Production Process
Figure 93. Regional Prescription Diet Production Cost Structure
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
